Found: 48
Select item for more details and to access through your institution.
Osimertinib With Ramucirumab in EGFR-mutated, T790M-positive Patients With Progression During EGFR-TKI Therapy: Phase Ib Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Durvalumab for patients with unresectable stage III non-small cell lung cancer and grade 1 radiation pneumonitis following concurrent chemoradiotherapy: a multicenter prospective cohort study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 853, doi. 10.1007/s10637-020-01060-8
- By:
- Publication type:
- Article
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 1, p. 253, doi. 10.1007/s40487-022-00188-2
- By:
- Publication type:
- Article
Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1400097
- By:
- Publication type:
- Article
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00582-1
- By:
- Publication type:
- Article
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 11, p. 1783, doi. 10.1038/s41416-024-02662-2
- By:
- Publication type:
- Article
A DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 9, p. 3520, doi. 10.1007/s12325-024-02921-x
- By:
- Publication type:
- Article
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 11, p. 4928, doi. 10.1007/s12325-023-02648-1
- By:
- Publication type:
- Article
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Limb Salvage Surgery for Ponatinib-Induced Bilateral Chronic Limb-Threatening Ischemia in a Patient with Chronic Myeloid Leukemia with T315I Mutation in BCR-ABL: A Case Report.
- Published in:
- Annals of Vascular Diseases, 2024, v. 17, n. 1, p. 51, doi. 10.3400/avd.cr.23-00059
- By:
- Publication type:
- Article
Low tumor glutathione level as a sensitivity marker for glutamate‑cysteine ligase inhibitors.
- Published in:
- Oncology Letters, 2018, v. 15, n. 6, p. 8735, doi. 10.3892/ol.2018.8447
- By:
- Publication type:
- Article
A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 7135, doi. 10.2147/CMAR.S208224
- By:
- Publication type:
- Article
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 596, doi. 10.1016/j.cllc.2021.04.006
- By:
- Publication type:
- Article
Single nucleotide variant sequencing errors in whole exome sequencing using the Ion Proton System.
- Published in:
- Biomedical Reports, 2017, v. 7, n. 1, p. 17, doi. 10.3892/br.2017.911
- By:
- Publication type:
- Article
Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant <italic>EGFR</italic> mutant non‐small‐cell lung cancer.
- Published in:
- Pathology International, 2018, v. 68, n. 3, p. 167, doi. 10.1111/pin.12630
- By:
- Publication type:
- Article
Continuous immunotherapy beyond progression in clinical practice for small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 15, p. 1271, doi. 10.1111/1759-7714.15308
- By:
- Publication type:
- Article
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report.
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 16, p. 2394, doi. 10.1111/1759-7714.14563
- By:
- Publication type:
- Article
Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: Multicenter, single-arm, phase 2 trial (ABC Study).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Anti-sortilin1 Antibody Up-Regulates Progranulin via Sortilin1 Down-Regulation.
- Published in:
- Frontiers in Neuroscience, 2020, v. 11, p. N.PAG, doi. 10.3389/fnins.2020.586107
- By:
- Publication type:
- Article
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor: Comparison between T790M mutation-positive and mutation-negative populations.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 24, p. 4325, doi. 10.1002/cncr.28364
- By:
- Publication type:
- Article
Assessment of exposure risk of irinotecan and its active metabolite, SN-38, through perspiration during chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 865, doi. 10.1177/1078155218769136
- By:
- Publication type:
- Article
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6777
- By:
- Publication type:
- Article
Liquid biopsy detects genomic drivers in NSCLC without EGFR mutations by single‐plex testing: WJOG13620L.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21097, doi. 10.1002/cam4.6668
- By:
- Publication type:
- Article
Medroxyprogesterone Acetate for Refractory Emesis in Cisplatin-Treated Patients.
- Published in:
- Journal of Palliative Medicine, 2012, v. 15, n. 10, p. 1158, doi. 10.1089/jpm.2011.0527
- By:
- Publication type:
- Article
Erlotinib for Pretreated Squamous Cell Carcinoma of the Lung in Japanese Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 12, p. 1366, doi. 10.1093/jjco/hyr159
- By:
- Publication type:
- Article
Higher osimertinib introduction rate achieved by multiple repeated rebiopsy after acquired resistance to first/second generation EGFR‐TKIs.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 746, doi. 10.1111/1759-7714.13822
- By:
- Publication type:
- Article
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial.
- Published in:
- International Journal of Hematology, 2022, v. 115, n. 4, p. 499, doi. 10.1007/s12185-022-03289-w
- By:
- Publication type:
- Article
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancerpatients treated with platinum-based doubletc hemotherapy.
- Published in:
- BMC Medical Genetics, 2010, v. 11, p. 167, doi. 10.1186/1471-2350-11-167
- By:
- Publication type:
- Article
Cystine and theanine for chemoradiotherapy-induced esophagitis in non-small cell lung cancer: a prospective observational study.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 6, p. 1, doi. 10.1007/s00520-024-08613-0
- By:
- Publication type:
- Article
Pemetrexed monotherapy for chemo-naïve elderly (aged ≥80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003).
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1267, doi. 10.1007/s00280-015-2755-2
- By:
- Publication type:
- Article
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 6, p. 1261, doi. 10.1007/s00280-015-2759-y
- By:
- Publication type:
- Article
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 17, doi. 10.1007/s00280-013-2290-y
- By:
- Publication type:
- Article
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230698, doi. 10.1001/jamanetworkopen.2023.0698
- By:
- Publication type:
- Article
Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 2, p. 415, doi. 10.3892/mco.2014.457
- By:
- Publication type:
- Article
Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.
- Published in:
- Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 454, doi. 10.3892/mco.2014.249
- By:
- Publication type:
- Article
Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130219
- By:
- Publication type:
- Article
Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L.
- Published in:
- Cancer Science, 2022, v. 113, n. 1, p. 221, doi. 10.1111/cas.15176
- By:
- Publication type:
- Article
Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer.
- Published in:
- Cancer Science, 2020, v. 111, n. 2, p. 561, doi. 10.1111/cas.14260
- By:
- Publication type:
- Article